FDA ODE II Directorship Open; Kweder Tapped As Office Of New Drugs Deputy
Executive Summary
FDA is looking to fill the Office of Drug Evaluation II director position following the appointment of Sandra Kweder, MD, to the Office of New Drugs as deputy director
You may also be interested in...
FDA Pediatric/Counterterrorism Office Will Announce Division Directors In Fall
FDA's Office of Counterterrorism and Pediatric Drug Development (OCTAP) is expected to announce directors for its separate counterterrorism and pediatric drug divisions in the fall
FDA Pediatric/Counterterrorism Office Will Announce Division Directors In Fall
FDA's Office of Counterterrorism and Pediatric Drug Development (OCTAP) is expected to announce directors for its separate counterterrorism and pediatric drug divisions in the fall
ODE II Director Is Pulmonary & Allergy Division Chief Meyer
Pulmonary & Allergy Drug Products Division Director Robert Meyer, MD, will become Office of Drug Evaluation II director effective June 16